Elsevier

Metabolism

Volume 46, Issue 12, December 1997, Pages 1384-1389
Metabolism

Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa

https://doi.org/10.1016/S0026-0495(97)90136-0Get rights and content

Abstract

The study objective was to determine circulating levels of the appetite-controlling neuropeptides, neuropeptide Y (NPY), galanin, and leptin, in subjects with eating disorders. The study group consisted of 48 obese women aged 19 to 45 years, 15 women with anorexia nervosa aged 18 to 23 years, and 19 lean healthy women aged 18 to 42 years (control group). The obese women were divided into four groups: (A) body mass index (BMI) = 25 to 30 kg/m2, n = 9 (overweight); (B) BMI = 31 to 40 kg/m2, n = 23 (moderate obesity); (C) BMI greater than 40 kg/m2, n = 9 (severe obesity); and (D) BMI = 31 to 40 kg/m2, n = 7 (moderate obesity + non—insulin-dependent diabetes mellitus [NIDDM]). Plasma NPY, galanin, and leptin concentrations were measured in peripheral blood samples with radioimmunoassay methods. Plasma NPY levels in obese women (groups A, B, C, and D) were significantly higher as compared with the control group (P < .01, P < .001, P < .001, and P < .001, respectively). The highest plasma NPY concentrations were observed in obese women with NIDDM. Plasma galanin levels were significantly higher in groups B, C, and D (P < .001, P < .001, and P < .001, respectively). Plasma leptin concentrations were significantly higher in groups C and D as compared with the control group (P < .001 and P < .001, respectively). Plasma NPY and galanin concentrations in women with anorexia nervosa did not differ from the levels in the control group. However, plasma leptin concentrations were significantly lower in anoractic women than in the control group (P < .01). Our results indicate that inappropriate plasma concentrations of NPY, galanin, and leptin in obese women may be a consequence of their weight status, or could be one of many factors involved in the pathogenesis of obesity.

References (68)

  • JF Hyde et al.

    Galanin gene expression in the hypothalamo-pituitary axis of the Ames dwarf mouse

    Mol Cell Neurosci

    (1993)
  • B Baranowska

    A marked decrease of vasoactive intestinal peptide release in obese patients

    Metabolism

    (1991)
  • B Baranowska

    Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa?

    Psychoendocrinology

    (1990)
  • A Sahu et al.

    Neuropeptidergic regulation of feeding behavior—Neuropeptide Y

    Trends Endocrinol Metab

    (1993)
  • JH Moltz et al.

    Neuropeptide Y: Direct and indirect action on insulin secretion in the rat

    Peptides

    (1985)
  • GA Bray

    Food intake, sympathetic activity and adrenal steroids

    Brain Res Bull

    (1993)
  • HM Frankish et al.

    Neuropeptide Y, the hypothalamus, and diabetes: Insights into the central control of metabolism

    Peptides

    (1995)
  • E Ekblad et al.

    Neuropeptide Y co-exists and cooperates with noradrenaline in perivascular nerve fibers

    Regul Pept

    (1984)
  • JE Morley

    Neuropeptide regulation of appetite and weight

    Clin Endocrinol (Oxf)

    (1987)
  • SF Leibowitz

    Central physiological determinants of eating behavior and weight

  • PG Kopelman

    Neuroendocrine function in obesity

    Clin Endocrinol (Oxf)

    (1988)
  • J Gibbs et al.

    Effects of brain-gut peptides on satiety

  • K Tatemoto et al.

    Neuropeptide Y: A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide

    Nature

    (1984)
  • JT Clark et al.

    Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

    Endocrinology

    (1984)
  • SP Kalra et al.

    Neuropeptide Y: A novel peptidergic signal for the control of feeding behavior

    Curr Top Neuroendocrinol

    (1990)
  • JT Clark et al.

    Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats

    Endocrinology

    (1985)
  • SF Leibowitz

    Hypothalamic neuropeptide Y in relation to energy balance

    Ann NY Acad Sci

    (1990)
  • EV Borisova et al.

    Bimodal effect of neuropeptide Y on feeding and its antagonism by receptor blocking agents in rats

    Acta Physiol Hung

    (1991)
  • WM Bennet et al.

    Presence of neuropeptide Y and its messenger ribonucleic acid in human islets: Evidence for a possible paracrine role

    J Clin Endocrinol Metab

    (1996)
  • Y Zhang et al.

    Positional cloning of the mouse obese gene and its human homologue

    Nature

    (1994)
  • MW Schwartz et al.

    Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice

    Diabetes

    (1996)
  • H Hauner

    Adipocytes as a source and target of hormones: Recent developments in adipose tissue physiology

    Eating Patterns Weight Control

    (1996)
  • A Rökaeus

    Galanin, a newly isolated biologically active neuropeptide

    Trends Neurosci

    (1987)
  • LM Kaplan et al.

    Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary

  • Cited by (108)

    • Is there a hypothalamic basis for anorexia nervosa?

      2021, Handbook of Clinical Neurology
      Citation Excerpt :

      When injected peripherally, NPY increases body weight and stimulates accumulated fat mass (Kuo et al., 2007). So far, studies on NPY plasma levels in AN have been inconclusive since they describe either decreased (Baranowska et al., 2001; Escobar et al., 2002), increased (Beranová et al., 2009; Sedláčková et al., 2011; Niedźwiedzka et al., 2013), or unchanged (Baranowska et al., 1997) levels of the peptide. When circadian variations of NPY were taken into account, no differences were observed between AN and healthy controls (Galusca et al., 2015).

    • Spexin: A novel regulator of adipogenesis and fat tissue metabolism

      2018, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
    View all citing articles on Scopus

    Supported by scientific program no. 501-2-2-25-47/97.

    View full text